Scarica l'app Stockscreener
32.40
0.59%
0.19
Dopo l'orario di chiusura:
32.40
Precedente Chiudi:
$32.21
Aprire:
$32.305
Volume 24 ore:
637.99K
Relative Volume:
0.71
Capitalizzazione di mercato:
$2.57B
Reddito:
$517.15M
Utile/perdita netta:
$66.35M
Rapporto P/E:
39.45
EPS:
0.8212
Flusso di cassa netto:
$126.63M
1 W Prestazione:
-1.19%
1M Prestazione:
-11.45%
6M Prestazione:
-10.52%
1 anno Prestazione:
+9.61%
Intervallo 1D:
$32.00
$33.54
Intervallo di 1 settimana:
$29.45
$33.54
Portata 52W:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.40 | 2.56B | 517.15M | 66.35M | 126.63M | 0.8212 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Underweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Veracyte (VCYT): Needham Reaffirms "Buy" Rating with $48 Price T - GuruFocus
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48 - Moomoo
Needham reiterates Veracyte stock rating on bladder cancer test plans - investing.com
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares By Investing.com - Investing.com India
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares - Investing.com
Is Veracyte Stock a Smart Addition to Your Investment Portfolio at This Time? - bitget.com
Is Veracyte Stock the Right Pick for Your Portfolio Now? - Yahoo Finance Singapore
MACD Signal: Is Veracyte Inc stock a value trap2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
VCYT SEC FilingsVeracyte 10-K, 10-Q, 8-K Forms - Stock Titan
Veracyte price target lowered to $45 from $50 at Guggenheim - TipRanks
Exit Recap: Is Veracyte Inc a strong candidate for buy and hold2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Guggenheim Maintains Buy Rating, Lowers Price Target on VCYT to $45 | VCYT Stock News - GuruFocus
Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN
Veracyte (NASDAQ:VCYT) Price Target Lowered to $45.00 at Guggenheim - MarketBeat
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Does Veracyte (NASDAQ:VCYT) Deserve A Spot On Your Watchlist? - Moomoo
Veracyte (NASDAQ:VCYT) Shares Down 9.2%What's Next? - MarketBeat
Vanguard disaggregates reporting; lists zero holdings in Veracyte (VCYT) - Stock Titan
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Volatility Watch: Is Veracyte Inc stock a top performer YTDPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn
Veracyte, Inc. $VCYT Shares Sold by Nordea Investment Management AB - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Update Report: Should value investors consider Veracyte Inc2026 Trade Ideas & Weekly High Return Forecasts - baoquankhu1.vn
Veracyte (VCYT) Chief Dev and Tech Officer files initial Form 3 - Stock Titan
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares - Sahm
TGI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Westview Management dba Westview Investment Advisors Invests $1.38 Million in Veracyte, Inc. $VCYT - MarketBeat
Does Veracyte (VCYT) offer both strength and opportunity? - MSN
Veracyte Names Kevin Haas as Chief Development and Technology Officer - StreetInsider
Breakouts Watch: Can Veracyte Inc expand into new marketsQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story - simplywall.st
Veracyte appoints Kevin Haas as chief development officer By Investing.com - Investing.com Australia
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Veracyte (VCYT) Appoints New Chief Development and Technology Of - GuruFocus
Veracyte names Kevin Haas as Chief Development and Technology Officer - TipRanks
Veracyte names Kevin Haas as chief development and technology officer - marketscreener.com
Veracyte Names Kevin Haas As Chief Development And Technology Officer - TradingView
Veracyte Appoints Kevin Haas as Chief Technology Leader - TipRanks
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer - marketscreener.com
Veracyte appoints Kevin Haas as chief development officer - Investing.com
Veracyte (NASDAQ: VCYT) hires Kevin Haas as Chief Development and Technology Officer - Stock Titan
Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026 - marketscreener.com
Iron Triangle Partners LP Purchases New Position in Veracyte, Inc. $VCYT - MarketBeat
Fred Alger Management LLC Takes $26.35 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Bamco Inc. NY Decreases Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT is ArrowMark Colorado Holdings LLC's 7th Largest Position - MarketBeat
Veracyte Inc Stock (ISIN: US92347M1009) Holds Steady Amid Analyst Downgrade and Mixed Signals - AD HOC NEWS
Veracyte (NASDAQ:VCYT) Downgraded by Zacks Research to "Hold" - MarketBeat
Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat
Veracyte (VCYT) CAO awarded 10,525 RSUs in new equity grant - Stock Titan
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):